187 related articles for article (PubMed ID: 38112858)
1. Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1.
Lévy R; Escudier A; Bastard P; Briand C; Polivka L; Stoupa A; Talbotec C; Rothenbuhler A; Charbit M; Debray D; Bodemer C; Casanova JL; Linglart A; Neven B
J Clin Immunol; 2023 Dec; 44(1):5. PubMed ID: 38112858
[TBL] [Abstract][Full Text] [Related]
2. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.
Oikonomou V; Smith G; Constantine GM; Schmitt MM; Ferré EMN; Alejo JC; Riley D; Kumar D; Dos Santos Dias L; Pechacek J; Hadjiyannis Y; Webb T; Seifert BA; Ghosh R; Walkiewicz M; Martin D; Besnard M; Snarr BD; Deljookorani S; Lee CR; DiMaggio T; Barber P; Rosen LB; Cheng A; Rastegar A; de Jesus AA; Stoddard J; Kuehn HS; Break TJ; Kong HH; Castelo-Soccio L; Colton B; Warner BM; Kleiner DE; Quezado MM; Davis JL; Fennelly KP; Olivier KN; Rosenzweig SD; Suffredini AF; Anderson MS; Swidergall M; Guillonneau C; Notarangelo LD; Goldbach-Mansky R; Neth O; Monserrat-Garcia MT; Valverde-Fernandez J; Lucena JM; Gomez-Gila AL; Garcia Rojas A; Seppänen MRJ; Lohi J; Hero M; Laakso S; Klemetti P; Lundberg V; Ekwall O; Olbrich P; Winer KK; Afzali B; Moutsopoulos NM; Holland SM; Heller T; Pittaluga S; Lionakis MS
N Engl J Med; 2024 May; 390(20):1873-1884. PubMed ID: 38810185
[TBL] [Abstract][Full Text] [Related]
3. Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?
Philippot Q; Casanova JL; Puel A
Curr Opin Immunol; 2021 Oct; 72():318-323. PubMed ID: 34455138
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
Garelli S; Dalla Costa M; Sabbadin C; Barollo S; Rubin B; Scarpa R; Masiero S; Fierabracci A; Bizzarri C; Crinò A; Cappa M; Valenzise M; Meloni A; De Bellis AM; Giordano C; Presotto F; Perniola R; Capalbo D; Salerno MC; Stigliano A; Radetti G; Camozzi V; Greggio NA; Bogazzi F; Chiodini I; Pagotto U; Black SK; Chen S; Rees Smith B; Furmaniak J; Weber G; Pigliaru F; De Sanctis L; Scaroni C; Betterle C
J Endocrinol Invest; 2021 Nov; 44(11):2493-2510. PubMed ID: 34003463
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations.
Orlova EM; Bukina AM; Kuznetsova ES; Kareva MA; Zakharova EU; Peterkova VA; Dedov II
Horm Res Paediatr; 2010; 73(6):449-57. PubMed ID: 20407228
[TBL] [Abstract][Full Text] [Related]
8. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G; Pivin M; Hangan T; Yurkovskaya O; Pivina L
Autoimmun Rev; 2022 Aug; 21(8):103135. PubMed ID: 35690244
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O
N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
Myhre AG; Halonen M; Eskelin P; Ekwall O; Hedstrand H; Rorsman F; Kämpe O; Husebye ES
Clin Endocrinol (Oxf); 2001 Feb; 54(2):211-7. PubMed ID: 11207636
[TBL] [Abstract][Full Text] [Related]
12. Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Constantine GM; Lionakis MS
Immunol Rev; 2019 Jan; 287(1):103-120. PubMed ID: 30565240
[TBL] [Abstract][Full Text] [Related]
13. Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.
Jamee M; Mahdaviani SA; Mansouri D; Azizi G; Joneidi N; Ghaffaripour H; Eskandarzade S; Ghaini M; Marjani M; Moniri A; Migaud M; Casanova J; Puel A; Velayati A
Immunol Invest; 2020 Apr; 49(3):299-306. PubMed ID: 31588815
[TBL] [Abstract][Full Text] [Related]
14. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
[TBL] [Abstract][Full Text] [Related]
15. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ; Leung PSC; Zhang W; Ma X; Gershwin ME
Autoimmun Rev; 2018 Jan; 17(1):78-85. PubMed ID: 29108822
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism.
Cranston T; Boon H; Olesen MK; Ryan FJ; Shears D; London R; Rostom H; Elajnaf T; Thakker RV; Hannan FM
Eur J Endocrinol; 2022 May; 187(1):111-122. PubMed ID: 35521792
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in AIRE gene with autoimmune polyendocrine syndrome type 1.
Fardi Golyan F; Ghaemi N; Abbaszadegan MR; Dehghan Manshadi SH; Vakili R; Druley TE; Rahimi HR; Ghahraman M
Immunobiology; 2019 Nov; 224(6):728-733. PubMed ID: 31526676
[TBL] [Abstract][Full Text] [Related]
19. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
20. Autoinmune polyendocrinopathy.
Fernández Miró M; Colom Comí C; Godoy Lorenzo R
Med Clin (Barc); 2021 Sep; 157(5):241-246. PubMed ID: 33958142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
